The occurrence of neuroleptic malignant syndrome in patients on antipsychotic therapy and factors influencing its development ...

As the FDA prepares to render a verdict on BMS’ closely watched schizophrenia drug, BioSpace takes a closer look at the ...

Explore hyposexuality in bipolar disorder, including symptoms like low libido, reduced sexual desire, and difficulty ...

With an FDA action date of Sept. 26, Bristol Myers Squibb’s KarXT could soon be the first new type of schizophrenia drug in ...

Vortioxetine, identified using a novel screening method, may enhance glioblastoma treatment alongside standard therapies, ...

BMO Capital analyst Evan Seigerman maintained a Hold rating on Bristol-Myers Squibb (BMY – Research Report) today and set a price target ...

I never understood how dangerous high temperatures and humidity could be until I collapsed with heat exhaustion. How can I ...

New data presented by Teva at ECNP 2024* demonstrate switching to UZEDY at four weeks after the last dose of once-monthly Perseris® (RBP-7000) provided the most comparable pharmacokinetic (PK) profile ...

Researchers have discovered that the antidepressant vortioxetine effectively combats glioblastoma, a deadly brain tumor, in ...

When it comes to babies, drooling is common and usually considered normal. It is connected to their limited ability to swallow. Even as an adult, you may have experienced your saliva flowing out of ...

Researchers led by ETH Zurich Professor Berend Snijder have discovered a chemical that, at least in vitro, successfully combats glioblastomas: vortioxetine, an antidepressant. Scientists understand ...

Glioblastoma, a highly aggressive form of brain cancer, remains an incurable disease despite advancements in medical treatment. While doctors can use surgery, radiation, and chemotherapy to extend the ...